Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mid-Q Response Study

NCT04180696 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.

NCT NCT04180696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04180696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mid-Q Response Study
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Phase
Not applicable
Overall status
Completed
Start date
January 23, 2020
Completion date
March 28, 2024
Enrollment
177 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart failure nyha class ii, heart failure nyha class iii, heart failure nyha class iv, heart failure with reduced ejection fraction (hfref), left bundle-branch block